logo
The Biggest Soup Recalls In US History

The Biggest Soup Recalls In US History

Yahoo24-05-2025

Soup has always been a comforting staple in American households, offering warmth and nourishment across generations. Whether it's a steaming bowl of chicken noodle soup to nurse you back to health on a sick day, or a hearty tomato bisque out of an iconic red-and-white can, this dish is often associated with safety, simplicity, and nostalgia. But despite its wholesome image and trusted reliability, even this beloved meal hasn't been immune to being taken off shelves for the general public's protection.
Over the years, various soup products have been recalled due to contamination, mislabeling labels, and other hazards, sometimes leading to serious health risks — and even death — for consumers. These recalls have affected products across the board — from mass-market brands like Campbell's and Trader Joe's to regional and specialty food producers. While some soup recalls were due to typical reasons like the presence of foreign objects or mislabeling, one incident involving insects found in the soup can be considered among the strangest food recalls in U.S. history. These cases also cast a spotlight on how even trusted brands can fall short when safety protocols are breached.
Read more: Campbell's Chunky Soup Flavors, Ranked Worst To Best
For many, a warm bowl of tortilla soup has the perfect blend of comfort and spice that's hard to resist. But in April of 2025, that comforting feeling was interrupted by an unsettling discovery in a batch of tortilla soup: wood fragments. The source of the contamination was traced to cilantro in the soup that had been contaminated by an extraneous material — specifically, small pieces of wood that could pose a choking or injury hazard.
The affected soups were distributed in Illinois, Indiana, Michigan, and Ohio, much of it through food-service channels such as cafeterias, hospitals, and institutional kitchens. That meant consumers might not have purchased these soups directly, but they could still have unknowingly consumed them in a meal.
While no injuries or illnesses were reported at the time of the recall, the incident shows that even a minor ingredient like chopped cilantro can have major consequences when quality control breaks down. Campbell's was one of the brands affected by the recall, along with Life Cuisine, Molly's Kitchen, Sysco, Verve, and Crafted Market. Anyone who encountered the affected product was advised to discard it or return it to the place of purchase.
Trader Joe's is known for its quirky branding and cult-favorite snacks — but in July of 2023, the grocery chain faced an unusual issue that it probably wishes had stayed under wraps. Its Unexpected Broccoli Cheddar Soup was recalled after multiple reports of insects discovered in the frozen broccoli florets used in the product. The soup had been distributed widely, reaching store shelves in Florida, Illinois, California, Texas, Washington, Pennsylvania, and Connecticut. In total, 10,889 cases were affected, making this one of the biggest recalls in Trader Joe's history.
This incident raised eyebrows among even the brand's most loyal fans, with some even pointing out the coincidental link between the product name and the recall: unexpected. While the FDA actually specifies that small amounts of insect parts are allowed in food sold to the public, this level of contamination was too much for TJ's customers to stomach. The recall raised questions about supplier oversight and whether inspection protocols were thorough enough at the point of packaging. Trader Joe's encouraged customers to return the product for a full refund, but the damage to consumer trust was significant. This high-profile case shows that quality issues aren't limited to mass-production brands, and that smaller labels must also hold themselves to high food safety standards.
When consumers open a soup container, they expect to find savory ingredients — not fragments of a nitrile glove. But in August of 2021, a huge batch of chicken tortilla soup was recalled after reports of gray glove pieces in the product. The product, manufactured by Blount Fine Foods, was at the center of a recall that affected more than 6,300 pounds of soup. Sold in 16-ounce containers with a "Use By" date of September 9, 2021, the soup had been distributed to retailers in Arizona, Florida, Georgia, and Texas. One of the retailers affected was Panera Bread.
The contamination likely occurred during the packaging process, raising concerns about employee safety protocols. Consumers who bought these products were advised not to eat them. Instead, they were instructed to discard the items or return them to the store where they were purchased.
No injuries or illnesses connected to this soup were reported at the time of this recall, but the visual shock of finding glove pieces in their food probably left many consumers unsettled. An incident like this could lead people to try making their own homemade versions of their favorite products — our copycat recipe for Panera's chicken noodle soup would a good place to start if you're interested in trying this.
In early 2020, Kettle Cuisine Midco faced scrutiny after recalling some 200 pounds of soup due to misbranding and undeclared allergens. The product in question? A toddler-targeted lentil and beef soup, which turned out to contain noodles made with egg and wheat, two common allergens that weren't listed on the label. Packaged in 7-ounce containers emblazoned with a cute cartoon cow and colorful veggies, the soup had been sold online and shipped to customers in Connecticut, New Jersey, New York, Maryland, Pennsylvania, and Washington, D.C.
For health-conscious parents seeking allergy-safe options for young children, the mistake was a major concern. Even though the volume recalled was relatively small, the potential impact was significant. The mismatch between the product's intended demographic and the seriousness of the mislabelling made it especially troubling. This recall highlighted the importance of applying extra care when it comes to foods sold specifically for children, and provides an example of the need for enhanced controls when allergens are involved.
When it comes to ready-to-eat pantry essentials, Campbell's Homestyle soups are considered as dependable and comforting choices. But in April of 2017, that reputation took a hit after a labeling mistake took a toll on the canned food giant. Nearly 4,200 pounds of soup cans labeled as Homestyle Healthy Request Chicken with Whole Grain Pasta were found to contain a completely different product: Homestyle Healthy Request Italian-Style Wedding Spinach & Meatballs in Chicken Broth soup — which, to make matters even worse, contains milk.
Milk is one of the major allergens that must be declared on food labels under the Food Allergen Labeling and Consumer Protection Act (FALCPA). The recalled cans of Campbell's soup — all produced on February 13, 2017 — bore a "Best By" date of February 13, 2019, and were shipped to retailers in Florida. Campbell's urged consumers to return the affected products or dispose of them. Luckily, no adverse reactions were reported when the recall was declared, but the risk of an allergic response earned this recall Class I status — the most serious level, indicating the potential for life-threatening health consequences.
Consumers assume that the food they buy has passed rigorous safety checks — but in October of 2015, Rustico Foods reminded Americans that sometimes, even after all the supervision stages have been passed, errors can happen. The company issued a recall for some 2,659 pounds of poultry-based soup products after it was discovered they had been produced without federal inspection. The recalled soups were comfort-food staples like chicken matzo ball, turkey chili with beans, and chicken vegetable. These items were produced over nearly a monthlong period — during 2015 from September 24 through October 21 — and distributed to retailers in California.
At the time of the recall, no negative health impacts were reported from consumers eating these soups, but the revelation that these products bypassed inspection stirred up more than just broth — it raised serious questions about oversight and accountability. Federal inspection isn't just red tape; it's the backbone of food safety, ensuring that products are hygienic, accurately labeled, and free from contaminants. Without it, consumers are left to play a dangerous guessing game. Considering the tragedies that occurred because of the most deadly recalled foods in U.S. history, it's understandable that brand trust can evaporate overnight when safety protocols slip.
In August of 2012, Blount Fine Foods found itself in hot water (pun intended) after a food safety issue led to the recall of varied types of soup, including its Italian wedding soup with meatballs and its chicken and dumpling soup. The Class II voluntary recall stemmed from consumers discovering plastic fragments in these prepackaged soup varieties, which were sold under the Wegmans supermarket chain's private label.
Investigators determined that the plastic pieces likely entered these products during the production of their containers. Such a mistake can pose serious health risks — foreign objects such as plastic, metal, and wood fragments can cause choking or internal injuries. With a total of 4,100 pounds of these soups recalled, a considerable amount of the affected products reached Wegmans shelves and the kitchens of shoppers, but fortunately the soups caused no reported injuries at the point when the recall was announced.
Labeling errors might seem like minor slip-ups — but when allergens are involved, such mistakes can become potentially life-threatening to many consumers. In April of 2011, Bay Valley Foods had to recall 188,181 pounds of cans that were labeled as containing reduced sodium chicken noodle condensed soup, because it was discovered that some of those cans actually contained cream of chicken soup. Since the latter soup variety contains milk, and this ingredient was not listed on the label, the potential severity of this situation prompted a Class I recall notice.
For people with dairy allergies or severe lactose intolerance, consuming the mislabeled cream of chicken soup could have led to dangerous reactions. The recall affected soup produced for Walmart's Great Value private label, and it was distributed across 36 states and Puerto Rico. Although no allergic reactions related to the soup had been reported when the recall was initiated, at least one customer complained that the product was improperly labeled, indicating that a significant amount of the recalled soup cans may have reached the homes of consumers before this colossal food-safety mistake was discovered and rectified.
In February of 2005, New Jersey-based Aunt Kitty's Foods found itself in the middle of a huge safety scare when it voluntarily recalled its Wedding Bell Soup with Meatballs and Chicken, due to the presence of undeclared dairy ingredients. For many consumers, especially those who are lactose intolerant or who suffer from a milk allergy, this was more than just a labelling error — it was a serious health hazard.
The soup — a hearty blend sold under the World Classics brand in 19-ounce cans — was suspected of containing cheese among its ingredients, a dairy-based food that was not disclosed on the label. A total of 4,275 pounds of this product was distributed to retailers in Connecticut and Massachusetts, and all of it was subjected to this Class I recall. Unfortunately for the producer (and for consumers of its products), this would not be the last time that Aunt Kitty's Foods would be subjected to a recall — in 2023, the company was caught up in one of the biggest chicken pot pie recalls in U.S. history.
Being in business for over 150 years, Campbell's is undoubtedly a food-industry giant. Nonetheless, a wide variety of its products have been caught up in the biggest recalls in Campbell's history. In February of 2003, the company issued a recall of its Italian Sausage with Pasta and Pepperoni Soup due to the presence of an undeclared dairy ingredient. The product contained Romano cheese, which was not listed on the label, and the concern was serious enough to warrant federal attention with a Class I recall. In total, 56,000 pounds of soup were pulled from shelves to keep consumers safe.
The soup was produced in a Campbell's plant located in Napoleon, Ohio, and it had been distributed to Costco locations in Alaska, Idaho, Montana, Oregon, Texas, Utah, and Washington. Complicating the incident, this Italian Sausage with Pasta and Pepperoni Soup was packaged in variety-pack cartons along with cans of a chicken-based product that was not subjected to any recall. This massive mistake showed that safety gaps can occur even amid facilities operated by well-established food producers.
Thanks to the work of Andy Warhol, cans of Campbell's soup transcended the kitchen to become American pop culture icons, highlighting a simple, reliable, and comforting image. But in 2002, the company had to issue a recall that shook consumers' confidence. The problem was that nearly 20,000 cases of its classic tomato soup — with a dozen 18.7-ounce cans in each case — were found to contain undeclared milk and soy.
The mix-up was traced to a single day's production of this soup variety, which resulted in a small amount of soup that contained milk and soy being packaged in containers that did not list these ingredients on the label. Distributed across at least 37 states from coast to coast, the reach of the affected product was extensive. Luckily, after receiving customer complaints, Campbell's acted quickly, initiating this recall and issuing a public warning to prevent any harm to its customers. Anyone who bought the soup was encouraged to return it to the point of sale for a full refund.
In December of 1992, Campbell's Soup Company faced a major recall involving both soups and frozen dinners — which is a reminder that there are numerous red flags to look out for when buying frozen foods. The issue this time involved the presence of glass shards that had accidentally found their way into the products during production.
The recall affected some 423,000 cans of soup and around 332,000 frozen dinners, leading to a widespread advisory to all areas where these products were distributed — including at least 33 states, as well as Guam and Mexico. Campbell's soup varieties that were impacted by the recall included chicken with rice and chicken gumbo.
The glass pieces were found in bags of rice that were sourced from an external supplier, but used in varied Campbell's products. Thankfully, despite the huge risks, at the time of the recall there were no reports of injuries caused by the sharp shards.
One of the most infamous soup-related recalls in American history dates back to 1971, when a can of Bon Vivant's vichyssoise soup became the focal point of a deadly botulism outbreak. After a couple in New York consumed the soup, the husband died within hours, and his wife was hospitalized in critical condition. Laboratory testing later confirmed the presence of botulinum toxin, a deadly pathogen that can be introduced to foods due to improper canning processes.
Fearing widespread contamination, the FDA moved to recall all soups, sauces, and canned foods produced by Bon Vivant, which was based in Newark, New Jersey. Further investigation revealed that defective cans were found in multiple product lines offered by Bon Vivant — which included numerous foods sold under different brand names.
This incident sent shockwaves through the industry and the nation. It was no longer just a health crisis — it also became a turning point for changes in food safety regulations, particularly for canned goods. It also ultimately led to the company's downfall, as consumer trust evaporated almost overnight. More than 50 years later, the vichyssoise tragedy still serves as a sad reminder of how poor food safety practices can be lethal, and why regular inspections and safety checks are needed.
Read the original article on Mashed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Opinion - We're cancer doctors. Here's why Medicare Advantage fails America's elderly.
Opinion - We're cancer doctors. Here's why Medicare Advantage fails America's elderly.

Yahoo

time16 minutes ago

  • Yahoo

Opinion - We're cancer doctors. Here's why Medicare Advantage fails America's elderly.

'It's nothing,' Tom, a retired firefighter from rural Texas, thought when he had persistent stomach pain. After shedding 30 pounds in three weeks, his family physician ordered a CT scan. Tom was not concerned — after all, the 65-year-old had gotten Medicare Advantage earlier that year. Like millions, Tom switched his insurance after he was solicited by a broker who promised low premiums and a gift card. Absent from the sales pitch was the fact that Medicare Advantage plans — privately run and separate from government-funded traditional Medicare — often delay and deny coverage. One of us met Tom nearly three months after his CT scan, and his doctor discovered the abdominal mass. The job as the first oncologist he had been able to see after months of jumping through hoops was to get initial scans, identify an in-network provider, wait for further referral and approval processes and finally schedule and complete a biopsy. The delays became a death knell. Tom was diagnosed with Stage 3 pancreatic cancer. Tom's first question was, 'It's going to be fine, right?' Despite the urge to reassure him, Tom's life and treatment options were not up to a doctor. They were up to his insurance. The same insurance that delayed urgent testing and care. By definition, Medicare Advantage is meant to support elderly medical care and increase efficiencies; in function, it is a business model that allows the American government to decrease its liability for sick seniors. Instead of absorbing and managing costs, the responsibility is outsourced to third-party operators, such as UnitedHealth Group, Humana and CVS Health. While Medicare Advantage provides excellent coverage if you never get sick, this insurance can quickly become a precursor to medical bankruptcy if the patient develops a deadly disease, a highly probable outcome when you consider that nearly 40 percent of Americans get cancer in their lifetime. After nearly two decades of experimentation and $450 billion of taxpayer money, Medicare Advantage has proven porous in terms of corruption, fraud and abuse. Yet, 32.8 million elderly Americans (54 percent of the eligible Medicare population) are currently enrolled in Medicare Advantage. In 2023 alone, Medicare Advantage plans fully or partially denied 3.2 million prior authorization requests. No one, especially among folks facing the daily drudgery of fighting cancer, truly understands how the cogs within the insurance machine work. Few of our elderly patients fight the goliath institution, and many succumb to poorer health outcomes in their quest for lifesaving treatment. Last year, countrywide and across disease groups, 79 percent of patients who experienced a delay or denial of coverage paid out of pocket for medication at least sometimes. Unsurprisingly, more than 100 million Americans are in medical debt. Of those who appealed between 2019 and 2023, over 80 percent were approved, implying that the initial claims were valid. This game of attrition directly contradicts Medicare Advantage's promise to provide efficient, patient-centered healthcare. These denials are not just medically dangerous because they enable deadly diseases to progress unchecked. They are also emotionally erosive. Daily, we see patients shrink in the face of denials, unable to emotionally navigate the complex Medicare system and the immense pain, isolation and depression resulting from this behemoth that stands between their disease and their hope to be free of it. During one of Tom's chemo visits, with thousands of dollars worth of IVs in his veins, his skin pale and translucent, he realized he was begging his insurance at every turn to support him. Stories like Tom's reveal the truth: Medicare Advantage is unapologetically failing its elderly cancer patients. Sick American seniors deserve more than insurance coverage in name only. We advise our patients to avoid Medicare Advantage. The better choice is traditional Medicare, plus a secondary or supplemental insurance. Often, people do not enroll in supplemental insurance because they do not understand its importance, believe they will never get sick, miss the deadline for approval without a medical exam (you must do this within three months before or after your 65th birthday), or think it is too expensive. Although supplemental insurance costs nearly $500 a month (exact amounts vary based on age and income), choosing this add-on — and paying roughly $6,000 a year — is much more affordable than Medicare Advantage's yearly out-of-pocket (potentially adding up to $8,500) and fighting for approvals for basic treatment. On Medicare Advantage, Tom quickly reached his maximum yearly out-of-pocket of $8,500, but then it reset on Jan. 1. After four months of treatment, he was responsible for paying $17,000 for 16 months of care, on top of his insurance premiums, simply to receive standard care. Of course, if you are one of the fortunate few to have never experienced illness — and we hope you are — Medicare Advantage can be a cheaper option. The question is, how can we make Medicare Advantage advantageous for the vulnerable? There is a bipartisan opportunity to change the narrative around this insurance model. During his confirmation hearing as the head of the Centers for Medicare and Medicaid Services, Mehmet Oz criticized Medicare Advantage insurers for some of their practices. Strategic change — omitting out-of-pocket costs for cancer patients, curbing insurance companies' rights to deny claims submitted by doctors and speeding up the process — along with more rigorous oversight of the program are worthwhile goals the Trump administration and Congress should take on. While Democrats and Republicans disagree on many issues, we believe we can all agree that people like Tom — and the millions of other Americans enrolled in Medicare Advantage — deserve comprehensive and just care. Dr. Pramod Pinnamaneni, MD, MBA, and Dr. Nitya Thummalachetty, DrPH, are founders of the Nau Project, a start-up dedicated to helping everyday Americans navigate the complexities of our healthcare system. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

RFK Jr. Bombarded Bill Nye With Endless Anti-Vax Text Screeds
RFK Jr. Bombarded Bill Nye With Endless Anti-Vax Text Screeds

Yahoo

timean hour ago

  • Yahoo

RFK Jr. Bombarded Bill Nye With Endless Anti-Vax Text Screeds

Robert F. Kennedy Jr. sent a flood of texts to Bill Nye trying to convince the beloved 'Science Guy' of his anti-vax claims. The old text chain, sent before Kennedy became Donald Trump's health secretary, was revealed by Nye during a Men's Health profile of the children's television presenter. The barrage of messages from the prominent vaccine skeptic, which the magazine described as 'miles and miles of texts,' contained numerous links to articles and websites peddling vaccine-autism conspiracies that Nye said he paid no real attention to. 'Just no self-awareness,' Nye said. 'And if you read these articles he sent, they're all this speculation about autism and just cause-and-effect, and mercury in vaccines, that maybe there's a connection. I wrote him back and said, 'Okay, I'll read your book. I think you've confused causation with correlation. Your friend, Bill.'' The stream of messages did not end there, Nye said, even after he told Kennedy, 'Okay, no more texts.' 'He started again! So I cut him off,' Nye said. 'He does not have good judgment. He is not suited for this job.' The Department of Health and Human Services did not immediately respond to a request for comment from the Daily Beast. Kennedy has led a full-blown assault on vaccines as part of the Trump administration's campaign to restore public 'trust' in the lifesaving shots. That includes the shock move to fire all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP), an expert panel that evaluates vaccine safety and efficacy. All had been appointed under the Biden administration. In a Wall Street Journal op-ed, Kennedy said vaccines had become a 'divisive issue in American politics' and that public confidence in the health agencies that provide them is 'waning.' Nye said the increase in vaccine skepticism, which soared amid the COVID-19 pandemic, is having real life negative consequences on people's lives. That includes the reaction to a measles outbreak in Texas that primarily hit unvaccinated individuals in the Mennonite community. 'It was a religious sect with historically low vaccination rates. And the argument from the other side is: They have rights not to get vaccinated. No, you don't,' a frustrated Nye said. 'Unvaccinated people can, and usually do, spread a disease. And that's why we have these rules, for public health! It's not arbitrary. It's not about your rights. It's about my rights, people.' Nye didn't hold back on Kennedy's bizarre public stunts either—like chugging raw milk with health influencer Dr. Paul Saladino to promote the Trump administration's initially error-riddled Make America Healthy Again report on childhood illness. 'And then this thing where people want to drink raw milk. No, you don't,' Nye said. 'This is very well understood! Louis Pasteur! You guyyys! What is happening?' For more, listen to Bill Nye the Science Guy on The Last Laugh podcast.

FDA Approves New 3-in-1 Combo Pill for High Blood Pressure
FDA Approves New 3-in-1 Combo Pill for High Blood Pressure

WebMD

time2 hours ago

  • WebMD

FDA Approves New 3-in-1 Combo Pill for High Blood Pressure

June 11, 2025 – The FDA has approved a new pill for adults with high blood pressure (hypertension) that combines three medicines in one. Available in one regular and two lower doses, it offers a convenient option for treating hypertension, which affects nearly half of the adults in the U.S. and raises their risk of stroke and heart failure. Sold as Widaplik, it is the first and only single pill to combine three previously FDA-approved drugs – telmisartan, amlodipine, and indapamide – offering a triple-action approach for people who would otherwise need multiple pills to manage their blood pressure. It works in three ways and is a safe, well-tolerated early treatment option. Hypertension happens when your blood pushes too hard against your blood vessels, making the heart work harder and increasing the risk of heart problems, strokes, and other complications. It contributes to about 460,000 deaths annually in the U.S. and often goes undetected due to a lack of symptoms. With 1 in 3 Americans unaware they have it and only 1 in 4 managing it well, there's an urgent need for simpler, more effective treatments. The approval was based on two large studies that showed using Widaplik helped lower blood pressure more than using just two medicines or a placebo, according to a news release from the company that makes it, George Medicines. People who took Widaplik didn't stop taking it more often because of side effects, which means it was generally easy for them to take. Another trial showed that Widaplik was better at reducing blood pressure compared to standard care, while remaining well-tolerated. George Medicines stated that a global trial is underway to find out if the combo treatment can help prevent strokes in people who have previously had an intracerebral hemorrhage (sudden bleeding in the brain), the most serious type of stroke. "Single-pill combination antihypertensive therapy has great potential to improve hypertension control in the US and worldwide. Most patients with hypertension need multiple therapies to achieve their blood pressure goals. The new dose options available with Widaplik offer a treatment regimen that could benefit a broad range of patients, including those just starting treatment," Paul Whelton, MD, Show Chwan chair of global public health at Tulane University in New Orleans and past president of the World Hypertension League, said in a statement. Widaplik is a medicine made of three drugs that work together to help lower blood pressure. Two of them, telmisartan and amlodipine, relax blood vessels so blood can flow more easily. The third, indapamide, helps your body get rid of extra water by making you pee more. Widaplik comes in three strengths: 10/1.25/0.625 mg, 20/2.5/1.25 mg, and 40/5/2.5 mg. Low blood pressure – which can make you feel faint or dizzy – was the most common side effect, the company said. Patients who pass out should stop taking the medication and consult their doctor.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store